Christopher R. Fenimore, SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,869 shares at $655.00 ($3.2M) on 2021-08-23, disclosed to the SEC on 2021-08-24.
Open-market sale of $3.2M REGN by SVP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $655.00 | 4,576 | $3.0M | 93.9% |
| 2 | $659.33 | 9 | $6K | 0.2% |
| 3 | $660.33 | 23 | $15K | 0.5% |
| 4 | $661.89 | 88 | $58K | 1.8% |
| 5 | $661.89 | 88 | $58K | 1.8% |
| 6 | $662.78 | 1 |
| $663 |
| 0.0% |
| 7 | $663.05 | 70 | $46K | 1.5% |
| 8 | $665.21 | 14 | $9K | 0.3% |
| Total | $655.43 avg | 4,869 | $3.2M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |